Modulating the bioactivity of nitric oxide as a therapeutic strategy in cardiac surgery
O Pisarenko, I Studneva - journal of surgical research, 2021 - Elsevier
Cardiac surgery, including cardioplegic arrest and extracorporeal circulation, causes
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
[引用][C] Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery
O Pisarenko, I Studneva - Journal of Surgical Research, 2021 - elibrary.ru
Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery
O Pisarenko, I Studneva - Journal of Surgical …, 2021 - journalofsurgicalresearch.com
Cardiac surgery, including cardioplegic arrest and extracorporeal circulation, causes
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery.
O Pisarenko, I Studneva - The Journal of Surgical Research, 2020 - europepmc.org
Cardiac surgery, including cardioplegic arrest and extracorporeal circulation, causes
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery
O Pisarenko, I Studneva - The Journal of surgical research, 2021 - pubmed.ncbi.nlm.nih.gov
Cardiac surgery, including cardioplegic arrest and extracorporeal circulation, causes
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …
endothelial dysfunction, which can lead to no-reflow phenomenon and reduction of …